341 related articles for article (PubMed ID: 17437785)
1. Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses.
Kunkle DA; Crispen PL; Li T; Uzzo RG
J Urol; 2007 May; 177(5):1692-6; discussion 1697. PubMed ID: 17437785
[TBL] [Abstract][Full Text] [Related]
2. Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
Lughezzani G; Jeldres C; Isbarn H; Perrotte P; Shariat SF; Sun M; Widmer H; Arjane P; Peloquin F; Pharand D; Patard JJ; Graefen M; Montorsi F; Karakiewicz PI
J Urol; 2009 Oct; 182(4):1287-93. PubMed ID: 19683281
[TBL] [Abstract][Full Text] [Related]
3. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
[TBL] [Abstract][Full Text] [Related]
4. Enhancing renal masses with zero net growth during active surveillance.
Kunkle DA; Crispen PL; Chen DY; Greenberg RE; Uzzo RG
J Urol; 2007 Mar; 177(3):849-53; discussion 853-4. PubMed ID: 17296355
[TBL] [Abstract][Full Text] [Related]
5. Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.
Mason RJ; Abdolell M; Trottier G; Pringle C; Lawen JG; Bell DG; Jewett MA; Klotz L; Rendon RA
Eur Urol; 2011 May; 59(5):863-7. PubMed ID: 21353376
[TBL] [Abstract][Full Text] [Related]
6. Predictors of locally advanced and metastatic disease in patients with small renal masses.
Kates M; Korets R; Sadeghi N; Pierorazio PM; McKiernan JM
BJU Int; 2012 May; 109(10):1463-7. PubMed ID: 21933329
[TBL] [Abstract][Full Text] [Related]
7. Primary tumor size in renal cell cancer in relation to the occurrence of synchronous metastatic disease.
Zastrow S; Phuong A; von Bar I; Novotny V; Hakenberg OW; Wirth MP
Urol Int; 2014; 92(4):462-7. PubMed ID: 24642839
[TBL] [Abstract][Full Text] [Related]
8. Metastatic renal cell carcinoma risk according to tumor size.
Thompson RH; Hill JR; Babayev Y; Cronin A; Kaag M; Kundu S; Bernstein M; Coleman J; Dalbagni G; Touijer K; Russo P
J Urol; 2009 Jul; 182(1):41-5. PubMed ID: 19450840
[TBL] [Abstract][Full Text] [Related]
9. Metastatic potential of a renal mass according to original tumour size at presentation.
Umbreit EC; Shimko MS; Childs MA; Lohse CM; Cheville JC; Leibovich BC; Blute ML; Thompson RH
BJU Int; 2012 Jan; 109(2):190-4; discussion 194. PubMed ID: 21557795
[TBL] [Abstract][Full Text] [Related]
10. Synchronous renal masses in patients with a nonrenal malignancy: incidence of metastasis to the kidney versus primary renal neoplasia and differentiating features on CT.
Patel U; Ramachandran N; Halls J; Parthipun A; Slide C
AJR Am J Roentgenol; 2011 Oct; 197(4):W680-6. PubMed ID: 21940540
[TBL] [Abstract][Full Text] [Related]
11. The metastatic potential of renal tumors: Influence of histologic subtypes on definition of small renal masses, risk stratification, and future active surveillance protocols.
Daugherty M; Sedaghatpour D; Shapiro O; Vourganti S; Kutikov A; Bratslavsky G
Urol Oncol; 2017 Apr; 35(4):153.e15-153.e20. PubMed ID: 28202224
[TBL] [Abstract][Full Text] [Related]
12. Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy.
Simhan J; Canter DJ; Sterious SN; Smaldone MC; Tsai KJ; Li T; Viterbo R; Chen DY; Greenberg RE; Kutikov A; Uzzo RG
J Urol; 2013 Jan; 189(1):43-7. PubMed ID: 23164383
[TBL] [Abstract][Full Text] [Related]
13. Predicting growth of solid renal masses under active surveillance.
Crispen PL; Wong YN; Greenberg RE; Chen DY; Uzzo RG
Urol Oncol; 2008; 26(5):555-9. PubMed ID: 18774473
[TBL] [Abstract][Full Text] [Related]
14. Delayed intervention of sporadic renal masses undergoing active surveillance.
Crispen PL; Viterbo R; Fox EB; Greenberg RE; Chen DY; Uzzo RG
Cancer; 2008 Mar; 112(5):1051-7. PubMed ID: 18286513
[TBL] [Abstract][Full Text] [Related]
15. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
16. Risk of metastasis for T1a renal cell carcinoma.
Lee H; Lee JK; Kim K; Kwak C; Kim HH; Byun SS; Lee SE; Hong SK
World J Urol; 2016 Apr; 34(4):553-9. PubMed ID: 26245747
[TBL] [Abstract][Full Text] [Related]
17. Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004.
Cooperberg MR; Mallin K; Ritchey J; Villalta JD; Carroll PR; Kane CJ
J Urol; 2008 Jun; 179(6):2131-5. PubMed ID: 18423754
[TBL] [Abstract][Full Text] [Related]
18. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
19. Small renal tumors: correlation of clinical and pathological features with tumor size.
Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of benign lesions in renal masses smaller than 7 cm presumed to be renal cell carcinoma.
Akdogan B; Gudeloglu A; Inci K; Gunay LM; Koni A; Ozen H
Clin Genitourin Cancer; 2012 Jun; 10(2):121-5. PubMed ID: 22401753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
